BioCorRx Inc.
BICX
$0.2866
-$0.2034-41.51%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -100.00% | -- | -79.59% | -91.09% | -77.20% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -100.00% | -- | -79.59% | -91.09% | -77.20% |
| Cost of Revenue | -100.00% | -- | -- | -80.46% | 50.57% |
| Gross Profit | -100.00% | -- | -56.99% | -93.71% | -92.05% |
| SG&A Expenses | 20.99% | 76.86% | 16.78% | -5.77% | -3.28% |
| Depreciation & Amortization | 94.03% | 0.00% | 0.00% | 0.00% | -2.90% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 33.62% | 70.75% | 42.10% | -7.29% | -33.66% |
| Operating Income | -36.71% | -72.54% | -44.62% | 3.93% | 30.62% |
| Income Before Tax | -26.69% | -74.45% | -33.62% | -22.45% | 16.68% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -26.69% | -74.45% | -33.62% | -22.45% | 16.68% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 12,500.00% | 2,227.27% | 1,418.18% | -22.22% | -84.38% |
| Net Income | -20.25% | -71.70% | -31.97% | -22.49% | 16.49% |
| EBIT | -36.71% | -72.54% | -44.62% | 3.93% | 30.62% |
| EBITDA | -36.24% | -73.05% | -44.93% | 3.96% | 30.79% |
| EPS Basic | 18.43% | -34.38% | -18.07% | -8.28% | 25.73% |
| Normalized Basic EPS | 23.93% | -21.92% | -21.83% | -12.50% | -3.08% |
| EPS Diluted | 18.43% | -34.38% | -18.18% | -8.28% | 25.73% |
| Normalized Diluted EPS | 23.93% | -21.92% | -21.83% | -12.50% | -3.08% |
| Average Basic Shares Outstanding | 47.48% | 27.77% | 11.76% | 13.13% | 12.41% |
| Average Diluted Shares Outstanding | 47.48% | 27.77% | 11.76% | 13.13% | 12.41% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |